Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Moore KLF"'
Autor:
Røra M; Department of Clinical and Molecular Medicine Norwegian University of Science and Technology (NTNU) Trondheim Norway.; Department of Hematology St. Olavs Hospital Trondheim Norway., Solberg MS; Department of Clinical and Molecular Medicine Norwegian University of Science and Technology (NTNU) Trondheim Norway.; Department of Hematology St. Olavs Hospital Trondheim Norway., Moore KLF; KG Jebsen Center for B cell malignancies Institute of Clinical Medicine University of Oslo Oslo Norway.; Department of Hematology Oslo Myeloma Center Oslo University Hospital Oslo Norway.; Department of Hematology and Oncology Stavanger University Hospital Stavanger Norway., Slørdahl TS; Department of Clinical and Molecular Medicine Norwegian University of Science and Technology (NTNU) Trondheim Norway.; Department of Hematology St. Olavs Hospital Trondheim Norway.
Publikováno v:
EJHaem [EJHaem] 2024 May 29; Vol. 5 (4), pp. 669-676. Date of Electronic Publication: 2024 May 29 (Print Publication: 2024).
Autor:
Nørgaard JN; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway. jaknoe@ous-hf.no.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. jaknoe@ous-hf.no.; KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway. jaknoe@ous-hf.no., Moore KLF; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway.; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Slørdahl TS; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Hematology, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway., Vik A; Department of Hematology, University Hospital of North Norway, Tromsø, Norway.; Institute of Clinical Medicine, The Arctic University of Norway, UiT, Tromsø, Norway., Tvedt THA; Department of Hematology, Oslo University Hospital, Oslo, Norway.; Clinic for Medicine, Haukeland University Hospital, Bergen, Norway., Schjesvold F; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Apr 09; Vol. 14 (1), pp. 60. Date of Electronic Publication: 2024 Apr 09.
Autor:
Moore KLF; KG Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway; Department of Hematology, Oslo University Hospital, Norway; Department of Hematology and Oncology, Stavanger University Hospital, Norway. k.l.f.moore@medisin.uio.no., Turesson I; Department of Hematology, Skane University Hospital Malmo/Lund, Sweden., Genell A; Regional Cancer Center of the Western Region, Sahlgrenska University Hospital, Sweden., Klausen TW; Department of Hematology, Herlev Hospital, Denmark., Knut-Bojanowska D; Department of Hematology, Uddevalla Hospital, Sweden., Redder L; Department of Hematology, Odense University Hospital, Denmark., Sverrisdottir I; Department of Hematology, Sahlgrenska University Hospital, Sweden; Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Thorsen J; Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Denmark., Vangsted AJ; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Blimark CH; Department of Hematology, Sahlgrenska University Hospital, Sweden; Institution of Internal Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden.
Publikováno v:
Haematologica [Haematologica] 2023 Jun 01; Vol. 108 (6), pp. 1640-1651. Date of Electronic Publication: 2023 Jun 01.